$49.76
+0.21 (+0.42%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+68.22%
1Y
+86.30%
YTD
+69.95%
Open$49.96
Previous Close$49.55
Day High$50.19
Day Low$49.11
52W High$59.30
52W Low$25.28
Volume—
Avg Volume2.72M
Market Cap7.58B
P/E Ratio17.18
EPS$2.75
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$30.02
Above
SMA 200
$32.89
Above
RSI (14)
46.3
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+25.4% upside
Current
$49.76
$49.76
Target
$62.39
$62.39
$43.17
$62.39 avg
$72.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 581.97M | 1.04B | 1.08B |
| Net Income | 422.27M | 129.57M | 136.18M |
| Profit Margin | 72.6% | 12.5% | 12.7% |
| EBITDA | 116.51M | 169.61M | 170.48M |
| Free Cash Flow | — | 110.01M | 140.89M |
| Rev Growth | +504.9% | +16.6% | +24.3% |
| Debt/Equity | 1.10 | 0.33 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |